Vanberra Signal

PHARMASEAL

Curated by Signal

Developer of a SaaS based platform for biopharmaceutical companies to manage their clinical trials

Overview

PHARMASEAL is a SaaS-based B2B clinical trial governance platform for biopharmaceutical companies to manage their clinical trials. The company is developing a cloud-based trial management platform that allows clinical trial operators to manage and monitor their clinical trials in accordance with good clinical practice (GCP) regulatory standards. The company also plans to develop modules such as a patient safety tool & a license and regulatory management tool. The company has developed a product called Engility that assist with the clinical trail study and task management.

Key facts

Founded
2016

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Reward-based application for tracking fitness activities

    Health TechnologyLondon, United Kingdom
  • Provider of smart sensory deprivation tanks for relaxation

    Health TechnologyLuton, United Kingdom
  • Provider of outsourced medical reporting solutions for general practices

    Health TechnologyBromsgrove, United Kingdom

About PHARMASEAL

What does PHARMASEAL do?

PHARMASEAL is a SaaS-based B2B clinical trial governance platform for biopharmaceutical companies to manage their clinical trials.

Where is PHARMASEAL headquartered?

PHARMASEAL is headquartered in Nottingham, United Kingdom.

When was PHARMASEAL founded?

PHARMASEAL was founded in 2016.

Which sector is PHARMASEAL in?

PHARMASEAL operates in Health Technology.

Who are PHARMASEAL's competitors?

Companies similar to PHARMASEAL include Fitlink, I-Sense Floatation, and iGPR.